hotspot -WSS

hotspot

author：focus 2025-09-27 09:55:04 - browse：53144

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Gilead might be held responsible for not developing a drug

Wikipedia

WSS

Senators start work on Medicare physician payment reform

The Readout: Gilead, Bernie Sanders, and other pharma news

Industry veterans launch new biotech VC with $310M

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Readout LOUD podcast: How biotech is using artificial intelligence

Health care court cases: Humana, Sutter, Novant

hotspot

hotspot

MORE: General Motors recalls over 600K cars due to car seat safety issue

focus

After affirmative action ruling, medical educators look to 'holistic review'

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Sports medicine is finally prioritizing gender equality

The system is set up to fail children with medical complexity

Tori Bowie and the unacceptable rates of Black maternal death

Doctors' information doesn't help them choose wisely when sick

Activists slam private health insurers over coverage restrictions

BioAge raises $170M for combination therapy with Zepbound

knowledge

Cigna wins case to block Amy Bricker's move to CVS

ALS patient reclaims some autonomy thanks to wearable 'robot'

Gilead might be held responsible for not developing a drug

Vaccine advisory panel ACIP left half staffed by HHS

BioAge raises $170M for combination therapy with Zepbound

'Essentially witchcraft:' A former naturopath takes on the field

focus

Wikipedia

leisure time

hotspot